Meet Dr. Lamm

Experience
Publications
Ask Dr. Lamm

Sign up online for a virtual consultation with Dr. Lamm, a pioneer in the treatment of bladder and other genitourinary cancers.

Printer Friendly

	ONCOVITE Antioxidant Multivitamins
Dr. Lamm's specially formulated and tested multivitamin tablets deliver a megadose of antioxidants that is beneficial when combined with BCG or other cancer treatment options. Order Oncovite Online

We subscribe to the HONcode principles.
Verify here.

Publications

Dr. Lamm is known around world for his pioneering research and clinical trials. He has a particular interest in immunotherapy and chemoprevention, and has authored or co-authored more than 270 publications.

In 1978, while at the University of Texas, Dr. Lamm along with Dr. Pinsky of Memorial Sloan Kettering Cancer Center, was awarded the first NIH-funded contract to evaluate BCG immunotherapy of superficial bladder cancer in a randomized clinical trial. This work resulted in the first controlled trial demonstrating the efficacy of intravesical BCG immunotherapy.

Dr. Lamm continues his research in BCG immunotherapy and chemoprevention, including a clinical trial showing reduced tumor recurrance in BCG patients adminstered megadoses of vitamins

2005 Publications

Donald L. Lamm, MD, FACS. BCG Immunotherapy of Superficial Bladder Cancer. Contemporary Urology. February, 2005.
A comprehensive review of the history of BCG and its practical application in superficial bladder cancer.
Murray S Feldstein, M.D. and Donald L Lamm M.D. Chapter 23: BCG maintenance for bladder tumours: what schedule and is it worthwhile? The Evidence for Urology. Dawson and Muir, editors, Gutenberg Press, Malta.
This text of evidenced-based medicine in urology is used to guide treatment decisions. A systematic review of the literature on BCG therapy revealed overwhelming evidence that BCG reduces tumor recurrence
Coming Soon! Thomas F. Hogan, M.D., Donald L. Lamm, M.D., and Daniel Rubin, N.D. Integrative Tumor Board: Transitional Cell Carcinoma of the Bladder. Complimentary Medicine.
A multidisciplinary approach to a difficult management problem, utilizing medical oncology, urology, and nutrition/complimentary medicine approaches.
Coming Soon! SIU/ICUD:2004 International Consensus Conference on Bladder Cancer: T1 Report. Alan M. Nieder , M.D., Maurizio Brausi, M.D., Donald Lamm, M.D., Michael O'Donnell, M.D., Kyouichi Tomita, M.D., Henry Woo, M.D., and Michael A.S. Jewett, M.D.
The international consensus on the management of lamina-propria invasive bladder cancer meeting was held in October, 2004. The report, to be published this year, compares BCG to cystectomy.
More Publications

The information available on and through the BCGOncology.com Web site is presented in summary form as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of qualified physicians and health care professionals. The information on BCGOncology.com has been obtained from sources believed to be accurate and reliable. However, BCG Oncology, PC makes no warranty as to the accuracy, reliability, or completeness of this information. Information accessed on or through BCGOncology.com is neither complete nor exhaustive and does not cover all disabilities, diseases, illnesses, and physical conditions or their management or treatment. Information accessed on and through BCGOncology.com is provided "AS IS" and without warranty, express or implied, including, but not limited to, any implied warranty of merchantability or of fitness for a particular purpose. View our terms of use for more information. Donald L. Lamm, MD is licensed to practice medicine in the state of Arizona, only.

Site design and development by Alamo Web Pros, www.AlamoWebPros.com.